| TTM
|
1/31/2026
|
1/31/2025
|
1/31/2024
|
1/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
302,970,000 | 215,938,000 | 130,497,000 | 60,922,000 | 26,974,000 |
|
Cost of Revenue
|
-76,729,000 | -62,475,000 | -32,639,000 | -16,621,000 | -11,618,000 |
|
Gross Profit
|
226,241,000 | 153,463,000 | 97,858,000 | 44,301,000 | 15,356,000 |
|
Selling, General and Administrative Expenses
|
-5,070,000 | -4,579,000 | -3,491,000 | -2,654,000 | -2,440,000 |
|
Research and Development Expenses
|
-23,592,000 | -18,497,000 | -12,914,000 | -8,675,000 | -7,339,000 |
|
Operating Income/Expenses
|
-28,662,000 | -23,076,000 | -16,405,000 | -11,329,000 | -9,779,000 |
|
Total Operating Profit/Loss
|
197,579,000 | 130,387,000 | 81,453,000 | 32,972,000 | 5,577,000 |
| Total Net Finance Income/Expense
|
1,766,000 | 2,041,000 | 1,539,000 | 609,000 | 5,000 |
| Irregular Income/Expenses
|
0 | -- | 0 | 0 | -1,353,000 |
|
Other Income/Expense, Non-Operating
|
6,692,000 | 9,022,000 | 1,034,000 | 237,000 | -48,000 |
|
Non-Operating Income/Expenses, Total
|
32,165,000 | 11,063,000 | 2,573,000 | 846,000 | -1,396,000 |
|
Pretax Income
|
229,744,000 | 141,450,000 | 84,026,000 | 33,818,000 | 4,181,000 |
|
Provision for Income Tax
|
-36,864,000 | -21,383,000 | -11,146,000 | -4,058,000 | 187,000 |
|
Net Income from Continuing Operations
|
192,880,000 | 120,067,000 | 72,880,000 | 29,760,000 | 4,368,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
192,880,000 | 120,067,000 | 72,880,000 | 29,760,000 | 4,368,000 |
|
Net Income after Non-Controlling/Minority Interests
|
192,880,000 | 120,067,000 | 72,880,000 | 29,760,000 | 4,368,000 |
|
Net Income Available to Common Stockholders
|
192,880,000 | 120,067,000 | 72,880,000 | 29,760,000 | 4,368,000 |
|
Diluted Net Income Available to Common Stockholders
|
192,880,000 | 120,067,000 | 72,880,000 | 29,760,000 | 4,368,000 |
|
Common Dividend per Share
|
0.28 | 0.04 | 0.03 | 0.02 | 0.02 |
| Basic EPS
|
7.95 | 4.93 | 2.97 | 1.21 | 0.18 |
| Diluted EPS
|
7.91 | 4.90 | 2.94 | 1.19 | 0.17 |
|
Basic Weighted Average Shares Outstanding
|
24,276,000 | 24,359,000 | 24,555,000 | 24,690,000 | 24,870,000 |
|
Diluted Weighted Average Shares Outstanding
|
24,397,500 | 24,514,000 | 24,804,000 | 24,940,000 | 25,070,000 |
|
Reported Normalized Diluted EPS
|
7.01 | 4.77 | 2.99 | 1.30 | 0.33 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
227,978,000 | 139,409,000 | 82,487,000 | 33,209,000 | 4,176,000 |
|
EBITDA
|
231,665,000 | 142,252,000 | 84,351,000 | 34,717,000 | 5,719,000 |
|
Normalized EBITDA
|
208,354,000 | 139,720,000 | 88,058,000 | 38,028,000 | 9,826,000 |
|
Normalized Income
|
170,821,000 | 116,997,000 | 74,265,000 | 32,312,000 | 8,366,000 |
|
Total Unusual Items
|
-23,311,000 | -2,532,000 | 3,707,000 | 3,311,000 | 4,107,000 |
1/31/2023 - 10/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade